EQS-News / 06/05/2021 / 12:26 UTC+8
[FOR IMMEDIATE RELEASE]
HSBC doubles EC Healthcare target price to HKD15.00 and reiterates "Buy" rating
EC Healthcare's third advanced imaging service centre commences operation
(6 May 2021, Hong Kong) EC Healthcare (the "Company", which together with its subsidiaries is referred to as the
"Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the
HSBC Global Research (HSBC) reiterates EC Healthcare's "Buy" rating and doubles the target price to HKD15.00 from
HKD7.50.
HSBC expects that China's aesthetic medical service market is to double by 2024 on rising acceptance of beauty
procedures and EC Healthcare is a major beneficiary as it is accelerating its expansion into the Greater Bay Area. The
Company is particularly well positioned underpinned by the following factors:
? The change of company name reflects the Company's strategy of becoming a leading one-stop medical healthcare
service provider in Asia and its rising focus on Mainland China.
? EC Healthcare's fast recovery amid the COVID-19 pandemic and the rebound of contract sales reflect its business
resilience and strong execution.
? The expected further relaxation of the cross-border travel quarantine requirements will act as a catalyst.
? HSBC expects the recent M&As to contribute considerably to the estimated 2021 earnings, while the organic expansion
of the Company, especially in the medical segment, remains on track.
? HSBC recognized that the introduction of two new strategic investors Dr. Cheng Chi Kong and Aspex Master Fund will
provide fresh capital for expansion and suggests potential collaboration.
In addition, the Group's new advanced imaging service center in Tsim Sha Tsui has commenced operation today to
complement its existing service offerings in Kowloon. The new centre located at Pacific Centre has a gross floor area
of approximately 3,200 square feet and offers state-of-art advanced imaging services such as Magnetic Resonance Imaging
(MRI) Scan, Computed Tomography (CT) Scan, X-ray and ultra sound. Together with the two existing advanced imaging
service centres in Mong Kok and Yuen Long, the total gross floor area of the Group's three advanced imaging service
centers is approximately 14,000 square feet.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "Preventive and
precision medicine has been one of the core business of the Group. To fulfill the demand for advanced imaging services,
the Group has established relevant service centers through organic growth to achieve further business synergy with
diversified medical and healthcare business units among the enclosed ecosystem of the Group. We believe the
aforementioned business expansion will become a growth driver for the Group's business, further consolidating the
Group's position in the industry as a one-stop comprehensive healthcare and medical service provider, and effectively
expanding its healthcare and medical market share."
- End -
About EC Healthcare
EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of
preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its
multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer
services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group
provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic
medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics
jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, New York Spine and
Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a
comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE,
a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL and NEW MEDICAL CENTER, obstetrics and gynaecology
specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE,
cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories and a professional hair care
center HAIR FOREST.
*According to an independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020
For further information, please contact:
iPR Ogilvy Limited
Callis Lau / Shana Li / Ada Chew
Tel: (852) 2136 6952 / 3920 7649 / 3920 7650
Fax: (852) 3170 6606
Email: ech@iprogilvy.com
File: HSBC doubles EC Healthcare target price to HKD15.00 and reiterates 'Buy' rating
06/05/2021 Dissemination of a Financial Press Release, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1193111&application_name=news(END) Dow Jones Newswires
May 06, 2021 00:27 ET (04:27 GMT)
